Description

S1316, Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction

This partially randomized clinical trial studies surgery or non-surgical management in treating patients with intra-abdominal cancer and bowel obstruction. Bowel obstruction is a common problem for advanced cancer patients and can negatively affect quality of life. It is not yet known whether surgery or non-surgical management is the best treatment option for bowel obstruction and can lead to better quality of life.

Patients must have malignant bowel obstruction due to an intra-abdominal primary cancer (i.e. stomach, small bowel [including duodenum], pancreas, colon, rectum, appendiceal, ovarian, uterine, cervical, kidney, bladder, prostate, gastrointestinal stromal tumor [GIST] [all sites], and sarcoma). For study details, see S1316, Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction.

Contact

Dr. Eric Silberfein ctsu-dldcc@bcm.eduPhone 1: (713) 798-8070
IRB: h-38885

Status

Active

Created

Oct 05, 2016